Neutralization of MERS coronavirus through a scalable nanoparticle vaccine

Abstract MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competen...

Full description

Bibliographic Details
Main Authors: Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, Zahra Gharailoo, Gheyath Nasrallah, Said Dermime, Kaspars Tars, Monique Vogel, Andris Zeltins, Martin F. Bachmann
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00365-w